ReTaMed ApS: Financial statements 2022
CVR: 39608405
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
ReTaMed ApS (CVR 39608405) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -17,823 and a net result of DKK -12,783 compared with DKK -56,913 the year before. Equity in the 2022 report amounted to DKK 108,423. The solvency ratio was 42.4%.
- Gross Profit
- DKK -17,823
- Profit/Loss
- DKK -12,783
- Equity
- DKK 108,423
- Total Assets
- DKK 255,878
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -18 t. | -13 t. | 108 t. | 0 |
| 2021 | - | -60 t. | -57 t. | 121 t. | 1 |
| 2020 | - | 350 t. | -238 t. | 178 t. | 1 |
| 2019 | - | 358 t. | -159 t. | 416 t. | 1 |
Official annual report
Keep an eye on ReTaMed ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
ReTaMed ApS has published its annual report for 2021. Gross profit came to DKK -59,628, and the net result was DKK -56,913.
As of July 6, 2022, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of ReTaMed ApS.
About ReTaMed ApS
ReTaMed ApS is a Danish company of the type Anpartsselskab based in Esbjerg, founded in 2018. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Henrik Fomsgaard-Knudsen. The company is owned by ReTaMed Holding ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -1,022 compared with DKK -861 the year before. Equity in the 2025 report amounted to DKK 50,000.